Position in AZN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$796,783
-$37,852 QoQ
Shares Held
4,202
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#724
of 1,459 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026THOROUGHBRED FINANCIAL SERVICES, LLC holds $37,562,101 across 10 Drug Manufacturers - General names. AZN ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,672 | $16,398,608 | |
| 2 | JNJ |
Johnson & Johnson
|
25,834 | $6,561,060 | |
| 3 | ABBV |
AbbVie Inc.
|
21,227 | $5,341,562 | |
| 4 | AMGN |
Amgen Inc
|
6,922 | $2,506,594 | |
| 5 | MRK |
Merck & Co., Inc.
|
17,635 | $2,266,097 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,803 | $1,364,851 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
18,341 | $1,056,808 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
4,202 | $796,783 |
All Filings in AZN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $796,783 | 4,202 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $834,635 | 4,232 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $779,106 | 8,475 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||